NEJM· Maurice Pérol Tatsuya Yoshida Myung-Ju Ahn Carl M. Gay Martin Schuler Haifeng Liu Ahmet Sezer Ahmet Bilici Ippokratis Korantzis Sun Min Lim Kohei Otsubo Oscar Juan-Vidal Yuanbin Chen Gustavo Schvartsman Haiyong Wang Anne-Marie C. Dingemans Jeffrey M. Clarke Aakash Desai Miguel Marigil Yuqi Chen Bazle Abidi Jessie Wang and Jacob Sandsthe DeLLphi-305 Investigators*·· 1 day agoPickScore66
Tarlatamab–Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer
In brief
NEJM published the DeLLphi-305 study online, evaluating the efficacy and safety of tarlatamab plus durvalumab as maintenance therapy for extensive-stage small-cell lung cancer.
Why it matters
DeLLphi-305, published in NEJM, reports key efficacy data for tarlatamab plus durvalumab maintenance in extensive-stage small-cell lung cancer.
Source: NEJM · nejm.org